Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

prourocare medical inc (PUMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/15 - $0.25
52 Week Low
12/29/14 - $0.0031
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

prourocare medical inc (PUMD) Related Businessweek News

No Related Businessweek News Found

prourocare medical inc (PUMD) Details

ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

2 Employees
Last Reported Date: 04/16/13
Founded in 1999

prourocare medical inc (PUMD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

prourocare medical inc (PUMD) Key Developments

ProUroCare Medical Files Form 15

ProUroCare Medical Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock, $0.00001 par value per share under the Securities Exchange Act of 1934, as amended.

ProUroCare Medical Inc. To Delist From The OTCQB And Deregister Its Common Stock, Units And Warrants

ProUroCare Medical Inc. announced that it intends to remove its common stock from trading on the OTCQB and to file a Form 15 with the Securities and Exchange Commission ("SEC") on or about March 14, 2014. The Company also announced that because its common stock, warrants and units are held by less than 300 holders of record and were held by less than 300 holders of record as of January 1, 2014, it expects to terminate the registration of its common stock, warrants and units under Section 12(g) and to suspend its reporting obligations under Section 15(d) of the Securities Exchange Act of 1934, as amended by filing the Form 15 with the SEC. The Company is taking this action in order to reduce the legal, accounting and administrative costs associated with being a reporting company under the Exchange Act and to allow the Company to explore options for a refinancing, restructuring or a sale of the Company or its assets without the burdens of its current public reporting status. There is no assurance that any such transaction will be completed. The Company anticipates that the OTCQB will suspend trading in the Company's common stock on the date the Company's Form 15 is filed with the SEC. Accordingly, the last day the Company's common stock will trade on OTCQB is on or about March 14, 2014. Upon filing the Form 15 with the SEC, the obligations of the Company to file certain periodic reports, including Forms 10-K, 10-Q and 8-K, will be suspended on a going forward basis. The Company anticipates that its common stock will commence quotation on the OTC Pink Marketplace after its delisting from the OTCQB to the extent market makers agree to make a market in its stock. No assurance, however, can be given that a trading market in the Company's common stock through the OTC Pink Marketplace will commence or be maintained.

ProUroCare Medical Inc. Announces Resignation of Robert Rudelius from the Board of Directors

On February 11, 2014, Robert Rudelius resigned from the board of directors of ProUroCare Medical Inc. and has told the company that he is planning to organize a group of investors to make a significant investment in the company.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PUMD:US $0.01 USD 0.00

PUMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PUMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation PUMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROUROCARE MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at